01 · The Question
How Far Can a Study Move From What Participants Originally Agreed To?
A study rarely changes all at once. One visit is added. A questionnaire becomes longer. Follow-up is extended. A procedure is modified. Each change may appear modest when viewed alone.
Eventually, however, researchers may face a harder question: are participants still taking part in substantially the study they agreed to, or have the accumulated changes made their original consent an inadequate basis for continued participation?
There is no universal numerical threshold. You cannot calculate that a study has changed by 20%, count three amendments, or compare two protocol versions and mechanically determine that consent has expired. Adequacy depends on what changed and what those differences mean for the participant's decision.
02 · The Short Answer
There Is No Fixed Amount of Change That Invalidates Original Consent
In Brief
Original consent becomes ethically inadequate when changes make the participant's current research experience or decision materially different from what they were originally informed about and agreed to, particularly when the differences could reasonably affect willingness to continue.
The threshold is qualitative rather than numerical. Researchers should examine the nature, significance, and cumulative effect of changes in risks, procedures, burdens, duration, alternatives, data practices, and other decision-relevant information, then follow the determination of the responsible research ethics committee or institutional review board.
03 · What You Need to Know
Consent Adequacy Depends on What Has Changed, Not How Many Amendments Exist
There Is No Percentage-of-Change Rule
Research ethics regulations and major international guidance do not provide a formula stating that original consent becomes inadequate after a specified number of amendments, months, additional procedures, or percentage of protocol change.
This makes sense because protocol changes are not ethically interchangeable. Ten administrative amendments might change nothing that matters to participants. One newly identified serious risk might fundamentally alter how a participant evaluates continued participation.
The more useful comparison is therefore not “old protocol versus new protocol” in the abstract. It is “the decision the participant originally made versus the decision the participant faces now.”
Protocol difference
How much the research plan, documents, procedures, administration, or scientific design has changed.
Consent-relevant difference
How much the information and conditions that could reasonably matter to the participant's voluntary decision have changed.
The second is the more important measure for consent adequacy.
Ask Whether the Original Description Is Still Substantially True
A useful starting point is to place the original consent information beside the study as it now exists. Consider whether the description participants relied on remains accurate enough to support their continuing choice.
Decision-relevant area
Question to compare
Why it matters
Purpose and nature of participation
Is the participant still contributing to essentially the research they were told about?
A substantially altered purpose or activity may change what participation means.
Procedures
Are participants now being asked to undergo materially different or additional activities?
New procedures can introduce different burdens, risks, or choices.
Risks and discomforts
Does the original information still fairly describe what is currently known?
Participants may evaluate participation differently when the risk profile changes.
Burden and duration
Has the time, frequency, inconvenience, cost, or duration of participation materially increased?
Burden can be relevant to a voluntary decision even when physical risk remains low.
Potential benefits and alternatives
Has information emerged that changes the options participants might reasonably consider?
The original decision may have been made using an outdated comparison.
Privacy and data use
Are information or specimens being handled or proposed for use within the scope participants understood?
Consent to one use does not necessarily establish authorization for every later use.
No single row automatically determines the answer. The table is a way to identify where the present study may have moved away from the basis of the participant's original decision.
Materiality Is More Useful Than Magnitude Alone
A change can be small operationally but large from the participant's perspective. Conversely, a substantial amount of behind-the-scenes protocol revision may have little relevance to participants.
OHRP advises IRBs considering changes in consent to examine whether those changes could affect a participant's understanding of the nature of the study or willingness to participate. SACHRP similarly emphasizes the nature of new information and whether a reasonable person would consider it important.
This introduces the idea of materiality : does the information matter enough that it could reasonably influence the participant's choice?
Small protocol change, potentially high materiality
A single sentence is added because investigators have learned of a serious previously unrecognized risk.
Large protocol change, potentially low materiality for an existing participant
Recruitment procedures are extensively redesigned after that participant has already enrolled, without changing the participant's remaining procedures or other decision-relevant information.
The number of edited pages tells you little about which situation has greater significance for consent.
Several Individually Modest Changes Can Accumulate
Researchers should not examine every amendment in isolation and forget what came before it. A sequence of individually modest changes may gradually produce a study that asks considerably more of participants than the version to which they originally agreed.
Imagine that a study initially requires four online surveys over six months. One amendment adds another survey. A later amendment extends follow-up by three months. Another adds an interview. None may appear dramatic alone, but together they have changed the duration, number of contacts, time commitment, and nature of participation.
This cumulative perspective follows from the underlying purpose of informed consent. The question is whether the participant remains adequately informed about the research in which they are actually participating, not whether each amendment was individually defensible when approved.
A Change Need Not Make the Original Consent Completely False
Consent adequacy is not an all-or-nothing test in which the original document remains perfect until suddenly becoming invalid. Much of it may remain accurate while one consequential part no longer does.
For example, the study purpose, confidentiality protections, and compensation may remain unchanged while the risk profile changes. That single difference may still be important enough to require new information and potentially renewed consent.
This is why deciding when participants should be asked to consent again requires attention to the significance of what has changed rather than merely asking whether the original form is still mostly accurate.
Not Every Difference Makes Original Consent Inadequate
At the other end of the spectrum, minor changes should not be inflated into ethical crises. OHRP specifically notes that nonsubstantive changes such as correcting typographical errors would not generally rise to the level requiring repetition of the consent process.
SACHRP also provides examples of study changes that may not need to be communicated to already enrolled participants when they do not affect them, such as increasing an upper age limit for enrollment or increasing the overall number of participants.
The appropriate threshold therefore sits somewhere between two unhelpful extremes: “any difference invalidates consent” and “the original signature covers everything that happens later.” Neither reflects consent as an ongoing, decision-centered process.
Substantive Change Is Recognized Across Major Ethical Frameworks
CIOMS states that, with research ethics committee approval, researchers should renew informed consent when there is a substantive change in the conditions or procedures of research or new information that could affect willingness to continue.
U.S. regulations use different language. The Common Rule requires, when appropriate, that participants receive significant new findings developed during research that may relate to willingness to continue. SACHRP notes that the regulations do not define a universal reconsent threshold or prescribe one mechanism for every situation.
ICH Good Clinical Practice likewise requires new information relevant to willingness to continue to be communicated in a timely manner and assessed to determine whether reconsent is needed. These frameworks are not identical legal standards, but they converge on a practical idea: decision-relevant change matters more than amendment counting.
Ethics Review Remains Essential Because Context Changes the Threshold
The same procedural change may carry different significance in different studies. Extending follow-up by one month might add little burden to an online observational study but considerably more burden to a trial requiring weekly travel, invasive procedures, or interruption of ordinary care.
Participant population also matters. Complexity, vulnerability, urgency, study phase, and the consequences of declining a new procedure can all affect how a change should be communicated and whether renewed consent is appropriate.
For this reason, researchers should not invent their own numerical threshold for adequacy. The proposed change and consent implications should be reviewed under the applicable research ethics and regulatory framework.
Watch Out
Do not divide a substantial change into several smaller amendments and then assess each only against the immediately preceding protocol. Consent adequacy should also be considered against what the participant originally understood and authorized. Otherwise, gradual change can become ethically invisible.
07 · A Quick Checklist
Check Whether the Original Consent Still Fits the Current Study
Compare the current study with the original consent:
Use the actual consent version under which the participant enrolled as your baseline.
Compare the original and current procedures, rather than merely counting protocol amendments.
Check whether risks, discomforts, burdens, duration, costs, or alternatives have materially changed.
Check whether privacy, confidentiality, data use, or specimen use has moved beyond what was originally described.
Consider whether several small changes have become important when viewed together.
Ask whether a reasonable participant could view the new information as important to the decision to continue.
Consider whether the changes are still relevant to this participant's remaining stage of participation.
Obtain the required ethics review of revised participant information and any proposed reconsent procedure before implementation.
11 · Cite this Guide
How to Cite This Guide
This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.
Recommended (Field Guide)
APA
MLA
Chicago
Copy Citation